EI
Elevian, Inc.
elevian.com
Website unreachable since Oct 18, 2026
The startup develops regenerative medicines that target the molecular mechanisms of aging by identifying blood factors that regulate biological repair and regeneration. Their approach aims to prevent and treat age-related diseases by reversing the damage caused by aging at a cellular level.
- Biotechnology
Updated 21 months ago
Funding
Raised to date
$60.8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops regenerative medicines that target the molecular mechanisms of aging by identifying blood factors that regulate biological repair and regeneration. Their approach aims to prevent and treat age-related diseases by reversing the damage caused by aging at a cellular level.